Signaling Pathways - MARK1 - 5-HT7 Receptors - Voltage-gated Sodium (NaV) Channels - ETA Receptors
清除全部
-
B5515 ProTx IITarget: Voltage-gated Sodium (NaV) ChannelsSummary: NaV1.7通道阻断剂 -
B7590 Quinidine中文名: 奎尼丁Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)Summary: 降低Na+和K+通道电流 -
B6872 IRL-2500Target: ETA Receptors|ETB ReceptorsSummary: 内皮素受体拮抗剂 -
B2268 Amiloride HCl dihydrate中文名: 盐酸阿米洛利二水合物Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: 有效上皮钠通道（ENaC）阻断剂 -
B1420 Bupivacaine HCl中文名: 盐酸布比卡因Target: Voltage-gated Sodium (NaV) ChannelsSummary: 麻醉药 -
B2272 Phenytoin sodium中文名: 苯妥英钠Target: Voltage-gated Sodium (NaV) ChannelsSummary: 钠通道稳定剂 -
B2274 Proparacaine HCl中文名: 盐酸丙美卡因Target: Voltage-gated Sodium (NaV) ChannelsSummary: 电压门控钠通道拮抗剂 -
B1477 Lurasidone HCl中文名: 盐酸鲁拉西酮Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂 -
B1490 Quetiapine Fumarate1 Citation中文名: 富马酸奎硫平Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺受体拮抗剂 -
B2075 Ambrisentan中文名: 安贝生坦Target: ETA ReceptorsSummary: ETA受体拮抗剂